Leaders of the treatment’s manufacturer, Amylyx, said they would announce their plans for it within eight weeks.
A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Market
Written by
in
Leaders of the treatment’s manufacturer, Amylyx, said they would announce their plans for it within eight weeks.
Written by
in